Cargando…
Design of Anticancer 2,4-Diaminopyrimidines as Novel Anoctamin 1 (ANO1) Ion Channel Blockers
Pyrimidine is a privileged scaffold in many synthetic compounds exhibiting diverse pharmacological activities, and is used for therapeutic applications in a broad spectrum of human diseases. In this study, we prepared a small set of pyrimidine libraries based on the structure of two hit compounds th...
Autores principales: | Kim, Taewoo, Cho, Sinyoung, Oh, Haejun, Hur, Joonseong, Kim, Haedong, Choi, Young-Ho, Jeon, Seongho, Yang, Young Duk, Kim, Seok-Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664333/ https://www.ncbi.nlm.nih.gov/pubmed/33172169 http://dx.doi.org/10.3390/molecules25215180 |
Ejemplares similares
-
Functional roles of glutamic acid E143 and E705 residues in the N-terminus and transmembrane domain 7 of Anoctamin 1 in calcium and noxious heat sensing
por: Choi, Jonghyun, et al.
Publicado: (2018) -
Anoctamin1 Induces Hyperproliferation of HaCaT Keratinocytes and Triggers Imiquimod-Induced Psoriasis-Like Skin Injury in Mice
por: Choi, Mi Ran, et al.
Publicado: (2021) -
Anoctamin-1 affects the migration and invasion of anaplastic thyroid carcinoma cells
por: Kim, Jae-Young, et al.
Publicado: (2019) -
Differences in Coformer Interactions of the 2,4-Diaminopyrimidines
Pyrimethamine and Trimethoprim
por: Alaa Eldin Refat, Lamis, et al.
Publicado: (2022) -
Anoctamin 1 contributes to inflammatory and nerve-injury induced hypersensitivity
por: Lee, Byeongjun, et al.
Publicado: (2014)